avatar
· Views 126
中药板块在9月的反弹中稍显弱势,因其前期表现相对生物制品、医疗器械等其他医药子板块更加抗跌稳健,政策也一直给予呵护,风格偏向医药防御性资产

Disclaimer: The views expressed are solely those of the author and do not represent the official position of Followme. Followme does not take responsibility for the accuracy, completeness, or reliability of the information provided and is not liable for any actions taken based on the content, unless explicitly stated in writing.

avatar
Reply 0

Leave Your Message Now

  • tradingContest